Anika Therapeutics Inc.

NASDAQ: ANIK · Real-Time Price · USD
14.52
-0.01 (-0.07%)
At close: May 01, 2025, 3:59 PM
14.46
-0.38%
After-hours: May 01, 2025, 04:05 PM EDT
-0.07%
Bid 13
Market Cap 205.76M
Revenue (ttm) 119.91M
Net Income (ttm) -56.38M
EPS (ttm) -0.6
PE Ratio (ttm) -24.19
Forward PE 26
Analyst Hold
Ask 16.07
Volume 33,929
Avg. Volume (20D) 72,395
Open 14.41
Previous Close 14.53
Day's Range 14.33 - 14.59
52-Week Range 12.83 - 29.12
Beta 0.81

About ANIK

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain manageme...

Sector Healthcare
IPO Date May 3, 1993
Employees 288
Stock Exchange NASDAQ
Ticker Symbol ANIK
Full Company Profile

Analyst Forecast

According to 2 analyst ratings, the average rating for ANIK stock is "Hold." The 12-month stock price forecast is $22, which is an increase of 51.57% from the latest price.

Stock Forecasts

Next Earnings Release

Anika Therapeutics Inc. is scheduled to release its earnings on May 9, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
6 months ago
-30.67%
Anika Therapeutics shares are trading lower after ... Unlock content with Pro Subscription